As the first targeted therapies edge towards regulatory approval, attention turns to the next drugs in line.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gao, M. et al. Nature 465, 96-100 (2010).
Lupberger, J. et al. Nature Med. doi:10.1038/nm.2341 (2011).
Related links
Rights and permissions
About this article
Cite this article
Ledford, H. New drug targets raise hopes for hepatitis C cure. Nature (2011). https://doi.org/10.1038/news.2011.256
Published:
DOI: https://doi.org/10.1038/news.2011.256